| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10511842 | Journal of Adolescent Health | 2009 | 8 Pages |
Abstract
The HPV-16/18 AS04-adjuvanted vaccine is immunogenic and well tolerated in boys aged 10 to 18 years. However, further data on the potential public health benefits of vaccination of boys are required before any recommendations can be made.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Tiina M.D., Heli M.D., Tiina M.D., Anna M.D., Sirkku M.D., Mari M.D., Helena M.D., Tuomas M.D., Olivier M.D., Matti M.D., Ph.D., Gary M.D.,